Patient registries are transforming medical research by bridging the gap between patients and researchers. 🤝 Our new whitepaper, "Connecting communities: Engaging patients in registries for long-term impact," reveals strategies for patient advocacy groups to create sustainable and impactful registries. From participant-centric design to innovative approaches like federated registries, we explore how these tools empower patients and drive medical advancements. 💪 Learn more.👇 https://lnkd.in/ePafWzgN #ClinicalTrials #PrecisionMedicine
Sano Genetics’ Post
More Relevant Posts
-
As you may have seen, today we're announcing a powerful new collaboration between Sano, 20/20 Onsite, and Clinical Enrollment that will drive major advancements in patient care and research outcomes for inherited retinal diseases (IRDs). This seamless, end-to-end solution combines cutting-edge technology and patient-centric services to support individuals affected by IRDs in ways that have never been possible before. Here's what the partnership looks like: 🧬 Sano will provide genetic testing, counseling, and a user-friendly platform for patients. 🚌 20/20 Onsite will deliver in-person screenings through mobile vision clinics. 💻 Clinical Enrollment will manage patient recruitment, medical record retrieval, and concierge support. This partnership aims to break down barriers, providing patients with easy access to expert care and enabling underserved communities to participate in research. By streamlining the process of identifying, screening, and enrolling participants, we’re not only accelerating clinical trials but also bringing vision-saving care to the people who need it most. This collaboration represents a big step forward in IRD research and patient empowerment, and we're proud to be a part of it. 🌟 And, there's a launch event at AAO in Chicago this evening – it's invite only, so please email events@sanogenetics.com if you'd like to attend! Learn more: https://lnkd.in/gVNvjKGJ #GeneticTesting #Ophthalmology #ClinicalTrials #IRDs #PrecisionMedicine #PatientCare
New partnership to boost access to specialist eye care and related research for patients across the USA
sanogenetics.com
-
Precision medicine is changing how we approach healthcare by focusing on more personalized and proactive care. In a recent blog post, we cover: 🎯 How precision medicine improves treatment outcomes 🧬 Its role in identifying individuals at risk for certain conditions 💰 Its potential for reducing healthcare costs Read below!👇 https://lnkd.in/eRqPJxVf #PrecisionMedicine #Healthcare #Genetics
Why does precision medicine matter?
sanogenetics.com
-
Inherited retinal disorders (IRDs) are a leading cause of genetic vision loss, affecting 1 in 1,380 people worldwide. These conditions, which include retinitis pigmentosa, Stargardt disease, and Leber Congenital Amaurosis (LCA), are caused by variants in over 280 genes. We’ve seen a few key developments: 🔬 Breakthrough gene therapies: For example, Luxturna for LCA caused by RPE65 gene variants has shown significant vision improvements. 💊 Emerging treatments: Up to 200 gene therapies for IRDs are currently in clinical trials, including promising therapies for X-linked retinitis pigmentosa. 🧬 Diagnostic advancements: Next Generation Sequencing techniques can now identify genetic variants in up to 70% of IRD cases, enabling more accurate diagnoses. But, challenges remain: 💸 High treatment costs 🧪 Limited access to genetic testing and specialized care 🔍 Difficulty identifying rare disease patients for clinical trials Moving forward, global collaboration between researchers, industry, and patient advocacy groups will be critical. Innovations like patient registries, increased genetic testing accessibility, and AI-driven diagnostics are expected to transform care for genetic eye disease patients. Sano looks forward to being at the forefront of these advances. If you’re interested in learning more, check out our latest whitepaper, written in collaboration with our partners 20/20 Onsite and Clinical Enrollment. 👇 https://lnkd.in/eh-8wFA4 #GeneticEyeDisease #PrecisionMedicine
Genetics in focus: Addressing the complexities of genetic eye disease and patient care
sanogenetics.com
-
Episode 157 of The Genetics Podcast is here! 🚀 In this episode, Patrick is joined by Mark Taylor, Head of Strategic Partnerships at LGC Group. Tune in to learn: 🧬 How genomics innovations can be scaled to benefit all NHS patients 🔬 Strategies for engaging underrepresented communities in medical research 🌏 The global importance of equitable access to precision medicine And much more! Listen by following the link below 👇 or simply search “The Genetics Podcast” on your go-to podcast platform. 🎧 https://lnkd.in/eeQMuWec 📽️ https://lnkd.in/eayJSV2j Please consider rating and reviewing us on your chosen podcast listening platform! #genetics #thegeneticspodcast #sanogenetics #precisionmedicine #genomics #healthcare #equity #innovation
-
-
This research from Prevail Therapeutics has the potential to make a real impact in the lives of those affected by FTD. We're so proud to support it. 🧠 #GeneticTesting #FTDResearch #NeurodegenerativeDiseases #PrecisionMedicine #Genomics #FTD
Could you be a part of the next breakthrough? At Prevail Therapeutics, we are passionate about advancing the conversation on genetic testing for rare diseases. Genetic testing involves analyzing a person’s DNA to identify changes or mutations in their genes or chromosomes, which can help in understanding and managing various conditions. Genetic testing can identify many disorders, including frontotemporal dementia (FTD). FTD is caused by mutations in the GRN gene in about 5–10% of cases. We are excited to highlight the Prevail and Sano Genetics Program that you can participate in from the comfort of your home. This study aims to better understand the genetics of FTD, empowering researchers to potentially identify treatment options. Free at-home genetic testing and counselling before and after your test are provided. To learn more and enroll visit: https://bit.ly/4f3y9ca Together, we can make a difference in the lives of those affected by FTD. #GeneticTesting #NeurodegenerativeDiseases #FrontotemporalDementia #PrevailTherapeutics #Research #Breakthroughs #AtHomeTesting #GeneticCounseling
-
-
Are you attending AAO this week in Chicago? 👁️ We'd love to see you! 👇
If you are attending American Academy of Ophthalmology in Chicago this week, and involved in precision medicines for IRD... We'd love for you to join us (Sano Genetics, 20/20 Onsite, Clinical Enrollment) to celebrate the launch of our new partnership! 🎉 The event is invite only, so please shoot us a message at events@sanogenetics.com if you'd like to join! Engaging participants for IRD trials requires a comprehensive solution, including multi-channel patient engagement, ophthalmology exams, and genetic testing. The coordination of these elements can be expensive and time consuming for trial sponsors and it can lead to missed opportunities for trial volunteers. We're bringing all of these key pieces together in a remote-first model, dramatically increasing accessibility for patients and accelerating trial enrolment for sponsors. If you can't make it, but want to learn more, comment here or send me a DM and we will follow-up.
-
-
In a recent episode of The Genetics Podcast, Patrick Short and Lon Cardon, Ph.D., CEO of The Jackson Laboratory, reflected on the shift from candidate gene studies to GWAS, the power of collaboration, and how rare disease research has opened doors to understanding more common conditions. Read a quick summary or listen in full on our blog:👇 https://lnkd.in/er5ah8TR #GWAS #Genomics #RareDiseases
Podcast recap: How genomics is rewriting the taxonomy of disease with Dr. Lon Cardon
sanogenetics.com
-
Genetic insights are reshaping how we approach Chronic Kidney Disease (CKD). Variants in genes like APOL1, PKD1, and PKD2 significantly influence both risk and progression. For researchers and drug developers, this presents opportunities to: 🧬 Enhance early diagnosis by identifying high-risk patients. 💊 Develop targeted therapies for genetic subtypes of CKD. 📊 Optimize clinical trials using genetic data for better patient stratification. Our latest blog covers the role of genetics in CKD and the potential of precision medicine. Take a read below. 👇 https://lnkd.in/ewrFQE82 #PrecisionMedicine #Nephrology #Genetics
Genetic risk factors for chronic kidney disease and their role in precision medicine
sanogenetics.com
